D-Wave Quantum: When Wall Street Trims Its Targets but Holds Its Conviction

D-Wave shares recover 14% but stay 55% below highs; analysts cut targets despite 1,120% bookings surge, highlighting a pivotal growth phase.

The most striking thing about D-Wave Quantum's summer on the markets isn't the numbers themselves — it's the contradiction between them. The stock has clawed back ground over recent weeks, yet analysts have spent that same period shaving their price targets. Both things are true, and both tell a different part of the same story.

Shares last changed hands at €18.45, up 2.7 percent on the day, having gained roughly 14 percent over the past 30 sessions. Strip out that short-term recovery, though, and the picture turns sobering: the equity remains about 19 to 20 percent below where it started the year, and it sits roughly 55 percent beneath its 52-week high of €40.41 — a gap that speaks to how thoroughly last autumn's enthusiasm has cooled.

The Analyst Paradox

The post-earnings reaction from the sell-side captures the tension perfectly. After D-Wave reported its quarterly figures on August 6 — revenue of $3.1 million against a consensus estimate of $4.03 million, and a loss per share of $0.13, wider than the $0.08 to $0.10 analysts had penciled in — a wave of target cuts followed. Mizuho's Vijay Rakesh trimmed his price objective from $35 to $29 on Thursday while keeping an "Outperform" rating. Jefferies, Evercore ISI, and Northland Securities made similar moves, lowering their targets to $40, $37, and $22 respectively, without abandoning their underlying buy recommendations.

That disconnect — lower targets, unchanged conviction — is what happens when a company is early on its commercial curve. The analysts believe in the destination; they just question the pace of travel. Wedbush's Matt Bryson captured the dual nature of the story when he initiated coverage on August 4 with an "Outperform" rating and a $40 price target, explicitly citing both commercial traction and progress against the technology roadmap.

Bookings Tell a Different Story Than the Income Statement

For all the disappointment in the headline revenue figure, the order book paints a markedly different picture. First-half 2026 bookings came in at $35.5 million — a 1,120 percent jump year over year — while remaining performance obligations climbed to $40.7 million, up 668 percent. That's not revenue yet, but it's the pipeline that will determine how D-Wave looks in the quarters ahead.

The company's balance sheet adds another layer of reassurance. As of June 30, D-Wave held $546.2 million in cash and marketable securities, a decline from earlier months that reflects the $250 million acquisition of Quantum Circuits. That's deliberate capital allocation into technology, not distress — a company building its pipeline while reported revenue lags behind is in transition, not decline.

A Physics Milestone and a Modest Grant

The scientific side of the ledger has been busy. On August 5, D-Wave published research in Nature demonstrating a two-qubit entanglement gate for its dual-rail architecture with 99.9 percent accuracy and a gate time of 500 nanoseconds — the kind of peer-reviewed validation that carries real weight in the quantum sector.

A week later came news of a smaller but symbolically significant funding award: up to 300,000 Canadian dollars from the National Research Council of Canada, earmarked for graph-embedding algorithms and annealing software for the Advantage2 system. The sum is modest next to the company's quarterly losses, but it underscores how reliant the quantum industry remains on public research money rather than organic revenue growth. Governments are placing early bets on technologies whose commercial maturity could still be years away — a reality of an industry in its pre-industrial phase, not a flaw in any single company.

The Bigger Grant Is Still in Limbo

The larger funding question — the up to $100 million outlined in a letter of intent under the CHIPS and Science Act, signed in June — requires more patience. The agreement also contemplates a possible equity stake for the U.S. government, but it remains a letter of intent, not a finalized award. The definitive approval documents have yet to be signed. Treating that as a secured injection of capital would be premature.

Building the Commercial Network

On the partnership front, D-Wave announced on August 3 a proof-of-concept with Nasdaq Verafin for quantum-hybrid applications aimed at detecting financial crime. Collaborations with established financial infrastructure players suggest the technology is generating commercial interest beyond pure research. The listing move from the NYSE to Nasdaq on August 1, keeping the QBTS ticker, is more symbolic than fundamental — but it fits a company repositioning itself squarely in the tech camp.

The Road Ahead

D-Wave's roadmap calls for a 17-qubit gate-model system by the end of 2026 and 100 logical qubits by 2032. The bookings surge and the Nature publication suggest a company building real substance. The revenue miss and the unresolved CHIPS Act funding argue for caution. The coming quarters will determine whether the order backlog finally translates into the income statement — and whether the analysts' patience, stretched but intact, proves justified.